Perhaps timely catching Apellis Pharmaceuticals Inc (APLS) would be a good idea

With 2.62 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.36 million shares. The 52-week range on APLS shows that it touched its highest point at $94.75 and its lowest point at $19.83 during that stretch. It currently has a 1-year price target of $83.58. Beta for […]

Get in on Apellis Pharmaceuticals Inc’s (APLS) buy-in window today!

With 0.69 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.52 million shares. The 52-week range on APLS shows that it touched its highest point at $94.75 and its lowest point at $19.83 during that stretch. It currently has a 1-year price target of $83.73. Beta for […]

Apellis Pharmaceuticals Inc (APLS) can make a big difference with a little luck

With 1.05 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.74 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $57.01 whereas the lowest price it dropped to was $55.45. The 52-week range on APLS shows […]

Apellis Pharmaceuticals Inc (APLS) can make a big difference with a little luck

With 2.8 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.13 million shares. The 52-week range on APLS shows that it touched its highest point at $94.75 and its lowest point at $19.83 during that stretch. It currently has a 1-year price target of $82.50. Beta for […]